Covidien signs deal to produce Mo-99 at Polish reactor

By Wayne Forrest, contributing writer

February 17, 2010 -- Healthcare technology firm Covidien of Dublin, Ireland, has inked an agreement with the Institute of Atomic Energy in Poland (IAE Polatom) to augment Covidien's supply of molybdenum-99 (Mo-99), used in the production of the medical isotope technetium-99m (Tc-99m).

The addition of IAE Polatom's Maria research reactor is expected to help Covidien meet the needs of more than 1 million additional patients globally in the first six months after the reactor begins supplying the isotope.

IAE Polatom recently made adjustments to its reactor for medical isotope production and completed a successful test of the manufacturing process this week. "The targets were subsequently processed by our facility in the Netherlands and everything went better than anticipated," said Elaine Haynes, vice president of commercial operations for Covidien's imaging business.

As soon as regulatory hurdles are cleared in Europe, Covidien plans to begin manufacturing and distributing medical isotopes within 30 days.

Haynes said the company currently is working with the U.S. Food and Drug Administration (FDA) to use Mo-99 from the Maria reactor in the U.S. While there is no specific date for supplies to arrive in the U.S., Haynes said, the additional supply in Europe will have a ripple effect in the U.S.

"As soon as we are able to use [Mo-99] in Europe, it begins benefiting the U.S., because we can use the Maria Mo-99 to free up supply from our other sources for Mo-99 for U.S. patients," she said.

Covidien also is seeking similar clearance from Health Canada for use of the medical isotope in that country as well.

The agreement comes two days before Dutch radiopharmaceutical producer Nuclear Research and Consultancy Group (NRG) is scheduled to close its High Flux Reactor in Petten, Netherlands, for six months for scheduled repairs.

Covidien will continue to get Mo-99 from current contracts with the BR2 reactor in Belgium, the Osiris reactor in France, and the Safari reactor in South Africa.

IAE Polatom's Maria research reactor is located approximately 20 miles southeast of Warsaw. It first began operations in 1975 and was taken offline in 1985 for a complete redesign. It resumed normal operations in 1993.

By Wayne Forrest staff writer
February 17, 2010

Covidien to halt generator production, January 22, 2010

Covidien pharmaceutical sales dip in fiscal Q1, January 20, 2010

Covidien to sell radiopharmacy business, December 17, 2009

Covidien shows mixed results in Q4, fiscal 2009, November 20, 2009

Covidien to modify Optimark labeling, November 9, 2009

Copyright © 2010


To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking